IMC Chicago’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Other funds holding CRSP
IMC Chicago's CRSP Position: Q3 2026 in Review
IMC Chicago sold out of CRISPR Therapeutics (CRSP) in Q3 2026, closing a stake of 10,709 shares — an estimated $578K sold.
IMC Chicago first reported a position in CRSP in Q1 2021 and held it in 15 quarters. The position peaked at $3.49M in Q4 2021. 504 funds tracked by Wall St. Rank hold CRSP as of Q3 2026.
- IMC Chicago reported no remaining CRISPR Therapeutics position as of Q3 2026 after selling out during the quarter.
- IMC Chicago sold 10,709 CRISPR Therapeutics shares in Q3 2026, an estimated $578K.
- IMC Chicago first reported a position in CRISPR Therapeutics in Q1 2021 and held it in 15 quarters.
- IMC Chicago's CRISPR Therapeutics position peaked at $3.49M in Q4 2021.
- 504 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2026.
Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.